PII S0196-9781(97)00294-5
Opioid Peptide Receptor Studies. 8. One of the
Mouse Brain
NCX
Binding Sites is Similar to the
Cloned Mouse Opioid Receptor: Further
Evidence for Heterogeneity of Opioid Receptors
HENG XU,* YI-FENG LU,* JOHN S. PARTILLA,* JULIA PINTO,² SYLVIA N. CALDERON,²
DOROTA MATECKA,² KENNER C. RICE,² JOSEPHINE LAI,‡ FRANK PORRECA,‡
SUBRAMANIAM ANANTHAN** AND RICHARD B. ROTHMAN*
1
*Clinical Psychopharmacology Section, Division of Intramural Research, NIDA, NIH, PO Box 5180,
5500 Nathan Shock Drive, Baltimore, MD 21224
²Laboratory of Medicinal Chemistry, NIDDK, NIH, Bethesda, MD 20892
‡Department of Pharmacology, College of Medicine, 1501 North Campbell Street, University of Arizona, Tucson, AZ 85724
**Organic Chemistry Department, Southern Research Institute, 2000 9th Ave. South, Birmingham, AL 35255
Received 11 July 1997; Accepted 10 September 1997
XU, H., Y-F. LU, J. S. PARTILLA, J. PINTO, S. N. CALDERON, D. MATECKA, K. C. RICE, J. LAI, F.
PORRECA, S. ANANTHAN AND R. B. ROTHMAN. Opioid peptide receptor studies. 8. One of the mouse
brain
NCX
binding sites is similar to the cloned moused opioid receptor: further evidence for heterogeneity of
opioid receptors. PEPTIDES 19(2) 343–350, 1998.—Quantitative ligand binding studies resolved two subtypes
of the opioid receptor, termed
ncx1
and
ncx2
, in mouse brain membranes depleted of receptors by
pretreatment with the irreversible ligand, BIT. The purpose of the present study was to compare the binding
parameters, ligand-selectivity profile and pharmacological properties of the cloned mouse receptor (MDOR)
stably expressed in a cell line to the
ncx
binding sites of mouse brain. [
3
H][D-Ala
2
,D-Leu
5
]enkephalin labeled
a single binding site in membranes prepared from MDOR cells under several different assay conditions including
BIT-pretreatment. The MDOR had high affinity for agonists and antagonists. [
3
H][D-Ala
2
,D-Leu
5
]enkephalin
labeled two binding sites in mouse brain membranes depleted of receptors by pretreatment with BIT: the
ncx1
site (high affinity for DPDPE and deltorphin) and the
ncx2
site (low affinity for DPDPE and deltorphin). Some
agents were moderately selective for the delta
ncx2
site: [pCl]DPDPE (10.9-fold), JP41 (5.9-fold) and JP45
(3.8-fold). The K
i
values of 12 opioids at the mouse MDOR were determined. These values were highly correlated
with their values at the delta
ncx1
site but not the delta
ncx2
site. These data suggest that the delta
ncx2
site may be
distinct from the cloned delta opioid receptor. © 1998 Elsevier Science Inc.
Delta receptors Receptor subtypes [D-Ala
2
, D-Len
5
]enkephalin
THE recent molecular cloning of , and
1
opioid receptors
(5,7,11,38,42) firmly established the heterogeneity of opioid
receptors as delineated on the basis of traditional pharmaco-
logical and biochemical approaches (1,6,8,14,16,22,24,32–34).
The relationship of other postulated opioid receptor subtypes to
the three cloned receptors is unclear. In regard to receptors,
a variety of pharmacological data support the existence of
receptor subtypes termed
1
and
2
receptors (10,17,18,36).
The recent finding that intracerebroventricular (ICV) adminis-
tration of an antisense oligodeoxynucleotide complementary to
1
Requests for reprints should be addressed to Dr. Richard Rothman, Division of Intramural Research, NIDA, NIH, PO Box 5180, 5500 Nathan Shock
Drive, Baltimore, MD 21224. E-mail: rrothman@lrp.nida.nih.gov
Peptides, Vol. 19, No. 2, pp. 343–350, 1998
Copyright © 1998 Elsevier Science Inc.
Printed in the USA. All rights reserved
0196-9781/98 $19.00 + .00
343